Mechanistically, antibody-based Tie2 activation induces VE-PTP-mediated VEGFR2 inhibition in tumor vessels in a ligand-independent manner, suggesting a potential strategy based on multiple mechanisms of action for regulating GBM vessels. Here, PTPRB is linked to neoplasm.